FTC official: Illumina/PacBio was a “future innovation story”

The US Federal Trade Commission’s deputy director of competition has shed light on her agency’s challenge to the now-abandoned Illumina/Pacific Biosciences deal.


Get unlimited access to all Global Competition Review content